Hs 616.T細胞 
	
		是否是腫瘤細胞:	1
	
	
		物種來源:	人
	
	
		數量:	大量
	
	
		生長狀態:	貼壁生長
	
	
		年限:	16 years
	
	
		運輸方式:	凍存運輸
	
	
		ATCC Number:	CRL-7378?
	
	
		相關**:	其他**
	
	
		Designations:	Hs 616.T
	
	
		Biosafety Level:	1
	
	
		Hs 616.T細胞Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	adherent
	
	
		Organism:	Homo sapiens
	
	
		Morphology:
	
	
		Source:	Disease: Hodgkin's lymphoma
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Cytogenetic Analysis:	modal number = 46; range = 45 to 46
	
	
		Age:	16 years
	
	
		Gender:	male
	
	
		Ethnicity: Hs 616.T細胞Caucasian
	
	
		Comments:	Part of the NBL Collection. Unlike other cell lines in the NBL Collection, this item has been fully accessioned by ATCC and is covered by the standard warranty.
	
	
		Please see the NBL Repository description.
	
	
		Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
	
	
		Temperature: 37.0°C
	
	
		Subculturing: Hs 616.T細胞Subcultivation Ratio: A subcultivation ratio of 1:2 is recommended
	
	
		Medium Renewal: Every 2 to 3 days
	
	
		Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.
	
	
		Add fresh culture medium, aspirate and dispense into new culture flasks.
	
	
		Preservation:	culture medium 95%; DMSO, 5%
	
	
		Related Products:	Recommended medium Hs 616.T細胞(without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
	
	
		recommended serum:ATCC 30-2020